Literature DB >> 8319187

Expression of antitumor response. Role of attachment and viability of bacillus Calmette-Guérin to bladder cancer cells.

H Akaza1, A Iwasaki, M Ohtani, N Ikeda, K Niijima, I Toida, K Koiso.   

Abstract

BACKGROUND: Antitumor effects of Bacillus Calmette-Guérin (BCG) against superficial urinary bladder cancer is known to be strong when BCG is directly infused into the bladder cavity. For expression of that effect, attachment of BCG to tumor cells is reported to be essential as the first step. Our study was conducted to elucidate the significance of attachment of BCG to tumor cells in inducing the antitumor effect.
METHODS: BCG, Tokyo 172 strain, in the form of live bacilli, lyophilized bacilli, or autoclaved bacilli was co-cultured with MBT-2, mouse-origin transitional cell cancer cells. Various preparations of BCG were mixed with MBT-2 cells and transplanted to male C3H/He mice to see tumor growth-inhibiting effect.
RESULTS: Both live and lyophilized BCG attached strongly to MBT-2 cells. The maximal attachment to the cells with live BCG occurred 24 hours earlier than with lyophilized BCG. When BCG was autoclaved, it lost the ability to attach to the cells. Lyophilized or autoclaved BCG exerted a marked tumor growth-inhibiting effects. This effect was equal to the Tokyo 172 strain and the Armand Frappier Canada strain. Histologically, a high degree of infiltration by macrophages was seen.
CONCLUSIONS: The results indicated that coexistence of BCG, even as killed by autoclaving, with tumor cells activates local immunity. Accordingly, the significance of the attachment of BCG to tumor cells in intravesical infusion therapy is surmised to lie in the fact that it results in retention of the BCG at the reaction site. This may provide a clue on how to approach future development of safer and more stable BCG-derived antitumor drugs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8319187     DOI: 10.1002/1097-0142(19930715)72:2<558::aid-cncr2820720237>3.0.co;2-h

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

Review 1.  The skin microbiome: current perspectives and future challenges.

Authors:  Yiyin Erin Chen; Hensin Tsao
Journal:  J Am Acad Dermatol       Date:  2013-03-13       Impact factor: 11.527

2.  Antiproliferative effects of bacillus Calmette-Guerin and interferon alpha 2b on human bladder cancer cells in vitro.

Authors:  K Pryor; P Stricker; P Russell; D Golovsky; R Penny
Journal:  Cancer Immunol Immunother       Date:  1995-11       Impact factor: 6.968

Review 3.  The skin microbiome and immune system: Potential target for chemoprevention?

Authors:  Mohammad Asif Sherwani; Saba Tufail; Anum Fatima Muzaffar; Nabiha Yusuf
Journal:  Photodermatol Photoimmunol Photomed       Date:  2017-08-30       Impact factor: 3.135

Review 4.  Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: current understanding and perspectives on engineered BCG vaccine.

Authors:  Koji Kawai; Jun Miyazaki; Akira Joraku; Hiroyuki Nishiyama; Hideyuki Akaza
Journal:  Cancer Sci       Date:  2013-01-03       Impact factor: 6.716

Review 5.  Enhancing Skin Health: By Oral Administration of Natural Compounds and Minerals with Implications to the Dermal Microbiome.

Authors:  David L Vollmer; Virginia A West; Edwin D Lephart
Journal:  Int J Mol Sci       Date:  2018-10-07       Impact factor: 5.923

6.  Natural Killer Anti-Tumor Activity Can Be Achieved by In Vitro Incubation With Heat-Killed BCG.

Authors:  Gloria Esteso; Nacho Aguiló; Esther Julián; Omodele Ashiru; Mei M Ho; Carlos Martín; Mar Valés-Gómez
Journal:  Front Immunol       Date:  2021-02-23       Impact factor: 7.561

7.  MyD88-dependent BCG immunotherapy reduces tumor and regulates tumor microenvironment in bladder cancer murine model.

Authors:  Nina M G P de Queiroz; Fabio V Marinho; Ana Carolina V S C de Araujo; Julia S Fahel; Sergio C Oliveira
Journal:  Sci Rep       Date:  2021-08-02       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.